WINNIPEG, MANITOBA -- (MARKET WIRE) -- November 07, 2006 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular focused biopharmaceutical company, today announced it will host an Analyst & Investor Day at 12:00 PM Eastern on Friday, November 17, 2006 in the Metropolitan Suite of the Four Seasons Hotel in New York City. The aim of the presentations is to provide institutional investors and analysts with a clinical and therapeutic update on Medicure’s acute cardiovascular products, MC-1 and AGGRASTAT(r). Presentations will be made by the Company’s senior management and cardiovascular opinion leaders, including:
